MR Imaging and Spectroscopic Study of Epileptogenic Hypothalamic Hamartomas: Analysis of 72 Cases

Jeremy L. Freeman; Lee T. Coleman; R. Mark Wellard; Michael J. Kean; Jeffrey V. Rosenfeld; Graeme D. Jackson; Samuel F. Berkovic; A. Simon Harvey

Abstract

BACKGROUND AND PURPOSE: Reports of MR imaging in hypothalamic hamartomas associated with epilepsy are few, and the number of patients studied is small. We aimed to detail the relationship of hypothalamic hamartomas to surrounding structures, to determine the frequency and nature of associated abnormalities, and to gain insight into mechanisms of epileptogenesis.

METHODS: We systematically examined MR imaging studies of 72 patients with hypothalamic hamartoma and refractory epilepsy (patient age, 22 months to 31 years). A dedicated imaging protocol was used in 38 cases. Proton MR spectroscopy of the hypothalamic hamartoma was performed for 19 patients and compared with the metabolite profile of the thalamus in 10 normal children and the frontal lobe in 10 normal adults.

RESULTS: Compared with normal gray matter, hypothalamic hamartomas were hyperintense on T2-weighted images (93%), hypointense on T1-weighted images (74%), and had reduced N-acetylaspartate and increased myoinositol content shown by MR spectroscopy. Hypothalamic hamartomas always involved the mammillary region of the hypothalamus, with attachment to one or both mammillary bodies. Intrahypothalamic extension (noted in 97%) tended to displace the postcommissural fornix and hypothalamic gray matter anterolaterally, such that the hypothalamic hamartomas nestled between the fornix, the mammillary body, and the mammillothalamic tract. Larger hamartoma size was associated with central precocious puberty. Associated findings of questionable epileptic significance included anterior temporal white matter signal intensity abnormalities (16%) and arachnoid cysts (6%). Malformations of cortical development were observed in only two patients, and hippocampal sclerosis was not observed.

CONCLUSIONS: Hypothalamic hamartomas can be readily distinguished from normal hypothalamic gray and adjacent myelinated fiber tracts, best appreciated on thin T2-weighted images. MR imaging and spectroscopy suggest reduced neuronal density and relative gliosis compared with normal gray matter. Associated epileptogenic lesions are rare, supporting the view that the hypothalamic hamartoma alone is responsible for the typical clinical features of the syndrome. The intimate relationship to the mammillary body, fornix, and mammillothalamic tract suggests a role for these structures in epileptogenesis associated with hypothalamic hamartomas.

Hypothalamic hamartomas are developmental malformations associated with central precocious puberty and gelastic (laughing) seizures (1). Evidence for the role of hypothalamic hamartomas in the production of gelastic seizures has been found only during the last decade, with stereotactic depth recording of seizure onset within hypothalamic hamartomas (2–5), production of typical gelastic seizures by depth electrode stimulation of hypothalamic hamartomas (4, 6) and ictal single photon emission CT studies showing hypothalamic hamartoma hyperperfusion (6–8). Surgical treatment of hypothalamic hamartomas for intractable epilepsy is increasingly advocated, and a number of approaches have been described, including microsurgical techniques (8–11), stereotactic RF coagulation (6, 12), and radiosurgery (13, 14). Consideration of the anatomy of the lesion in relation to the surrounding structures is essential when planning surgery (8–10, 14) and in anticipating potential neurologic and endocrine complications of treatment (15, 16); optimal radiologic display and detailed study of the intrahypothalamic relationships are therefore desirable.

The heavily myelinated white matter tracts of the hypothalamus (postcommissural fornices and mammillothalamic tracts) are readily visualized with MR imaging of cadaver brains (17), healthy volunteers, and patients with tumors involving the hypothalamus (18). These tracts may play a role in seizure propagation (19) and in the evolution of gelastic seizures to symptomatic generalized epilepsy in patients with hypothalamic hamartoma (20), but the MR anatomy of these tracts in relation to hypothalamic hamartomas has not been described and descriptions of mammillary body involvement are limited to the presence or absence of an attachment (21).

Previous reports of MR imaging findings of patients with hypothalamic hamartoma and epilepsy are either single case studies or small series, some supplemented by a review of the literature (21, 22). The larger published surgical series deal mainly with the results of hypothalamic hamartoma resection in cases of refractory epilepsy (9, 10). In the literature, controversy exists regarding the frequency and epileptic significance of malformations of cortical development associated with hypothalamic hamartomas (1, 23). We herein report the MR imaging appearance and spectroscopic findings of epileptogenic hypothalamic hamartomas, the relationship of hypothalamic hamartomas to hypothalamic white matter tracts and myelinated nuclei, and the nature and frequency of associated structural brain abnormalities.

Methods

We examined the MR imaging studies of 72 patients with hypothalamic hamartoma and epilepsy. Forty-three patients underwent formal assessment at this center, 37 of whom subsequently underwent surgery; histopathologic examination of the resected lesions in those cases revealed glial cells and neurons of normal appearance, in keeping with hamartoma. The remaining patients had MR images and clinical details provided by the referrer. The study was approved by the Ethics in Human Research Committees of the Royal Children’s Hospital and by the Human Ethics Committee of the Austin and Repatriation Medical Centre.

Imaging Protocol

Thirty-eight patients underwent MR imaging at this center. A 1.5-T clinical MR imaging system (Echospeed; GE Medical Systems, Milwaukee, WI) was used with software versions 8.35M and 9.0 and a standard quadrature transmit-receive head coil. The protocol consisted of sagittal view fast spin-echo (section thickness, 3.5 mm; intersection gap, 0.1 mm), axial view fast spin-echo (section thickness, 3 mm; intersection gap, 0.5 mm), sagittal view conventional spin-echo T1 (section thickness, 2.5 mm; intersection gap, 0.1 mm), and sagittal view 3D inversion-prepared fast spoiled gradient-echo (contiguous 0.6-mm sections) imaging. Dedicated coronal view images targeted to the hippocampus and anterior temporal lobes were acquired perpendicular to the long axis of the hippocampus and included fast spin-echo (contiguous 3-mm sections) and fluid-attenuated inversion recovery (contiguous 4-mm sections) images. 2D reconstructions of 3D fast spoiled gradient-echo volumes in sagittal and coronal planes (contiguous 2.5-mm sections) were obtained for review purposes.

For 34 patients, only studies obtained at other centers were reviewed. These varied in the number, type, and quality of sequences and planes of imaging performed; therefore, inclusion criteria were determined as follows: for hypothalamic hamartoma review, we required T1-weighted or gradient-echo or inversion recovery sequences, T2-weighted or proton density–weighted or fluid-attenuated inversion recovery sequences, and images obtained in two orthogonal planes, with section thickness of not more than 5 mm and intersection gap of not more than 1.5 mm in each sequence; for review of associated abnormalities, we additionally required whole brain images of two different sequences (as above) and coronal plus one other plane of imaging. Three additional patients were excluded from the study because of poor quality MR images. Contrast-enhanced studies were reviewed for 55 of 72 patients, but contrast medium was not administered as part of the imaging protocol at our center.

MR Imaging Review

A neuroradiologist (L.T.C.) and a neurologist (J.L.F.) together systematically examined all MR images by using a data entry form. Information obtained for each patient included number of studies, details of sequences performed, patient age, and time intervals between multiple studies when performed. Hamartoma data sought by visual inspection included signal intensity characteristics across sequences, position of lesion in relation to floor of third ventricle (intraventricular and interpeduncular extension), hypothalamic regions occupied by hamartoma in midsagittal section (mammillary, tuberal, supraoptic, preoptic), relation to optic chiasm and pituitary stalk, presence of asymmetric attachment to hypothalamus proper with description of this by category (right-sided, predominantly right-sided, bilateral, predominantly left-sided, left-sided), contact by either fornix with hamartoma and any fornix displacement, and contact by either mammillary body with hamartoma and any mammillary body displacement or deformity. Maximum diameter of the hypothalamic hamartoma in any plane was measured to the nearest millimeter with viewing software (eFilm; eFilm Medical, Toronto, Canada), for those patients whose studies were available in digital format, or by reference to calibration scales on hard copy films after digitization of images. Hypothalamic hamartoma size, location, and involvement of neuroendocrine structures were compared for patients with and without precocious puberty by using the two-sample t test for hypothalamic hamartoma size and Fisher’s exact test for categorical data; significance level was set at P < .05. Whole brain visual inspection included lobar organization and gyral arrangement; hippocampal size, shape, and signal intensity; anterior temporal white matter signal intensity and gray-white interface; appearance of white matter generally and of specific fiber tracts (anterior commissure, corpus callosum); ventricular, basal ganglia, brain stem, cerebellar, and major vessel appearance; and presence of associated developmental anomalies, including malformations of cortical development.

MR Spectroscopy

Short echo (30 ms) MR spectroscopy was performed at the same time as structural MR imaging for 19 patients (age range, 2–21 years; average age, 11.8 ± 5.7 years) who had not previously undergone hypothalamic hamartoma surgical procedures. A point-resolved spectroscopy sequence with two chemical shift selective imaging pulses for water suppression was used. Spectra were acquired with 128 transients of two k data points over a frequency width of 5000 Hz by using TR 1500. A single voxel was placed in the hypothalamic hamartoma, the size of which was tailored to fit the lesion. Two regions in normal volunteers were used for comparison. Using the same clinical MR imaging system and spectroscopy protocol (1500/30 [TR/TE]; transients, 128), a 1 × 1 × 1.2 cm voxel was placed in the left thalamus of 10 children (age range, 5–17 years; average age, 11.3 ± 4.6 years) who had normal structural MR imaging findings, normal cognitive development, and no history of seizures. On a different 1.5-T clinical MR imaging system (Echospeed GE-LX2, GE Medical Systems) with a similar point-resolved spectroscopy sequence (1500/35; transients, 128), a 2 × 2 × 2 cm voxel (including both gray and white matter) was placed in the right frontal lobe of 10 healthy adult volunteers with normal structural MR imaging findings.

Metabolite concentrations were determined for each region of interest by using computer software (LCModel) (24) and a library of reference spectra in a basis set recorded by the imaging unit manufacturer and calibrated with a 50 mmol/L N-acetylaspartate solution. Spectra were analyzed to provide information regarding total N-acetylaspartate content, choline-containing compounds, creatine plus phosphocreatine, glutamine plus glutamate, and myoinositol. Results are presented in institutional units (approximating millimolar concentration) based on this process. Comparison of metabolite concentrations between hypothalamic hamartomas and normal tissues was conducted by using one-way analysis of variance and a post hoc Bonferroni correction for multiple comparisons. The significance level was set at P < .05.

Results

Clinical Features

All patients had seizures that were refractory to antiepileptic medications. Seizure onset (known for 64 patients) was from birth to 16 years (median, 3 months). Patient age was 22 months to 31 years at the time of the last MR imaging study (mean, 12 years). A history of precocious puberty was present in 28 patients, absent in 39, and unknown for five. Two patients with multi-system malformations of the Pallister-Hall syndrome phenotype were excluded from the study because of poor quality MR images. Two included patients had postaxial polydactyly but did not meet established clinical criteria for Pallister-Hall syndrome (25). No other patients had malformations outside the CNS.

Twenty-eight patients had previously undergone neurosurgical procedures; 19 underwent procedures directed toward the hamartoma, and 13 underwent other procedures (four underwent both hamartoma and other neurosurgical procedures). Regarding hamartoma analysis, preoperative studies were available for seven of 19 patients who had undergone previous hypothalamic hamartoma procedures; for the other 12 patients, procedures undergone included partial resection (five patients), biopsy only (four), RF coagulation (two), and stereotactic radiosurgery (one). Regarding review of associated brain abnormalities, preoperative studies were available for only two of 13 patients who had undergone previous non-hamartoma neurosurgical procedures; for the other 11 patients, procedures undergone included temporal lobectomy (four patients), corpus callosotomy (two), drainage of arachnoid cyst (two), frontoparietal corticectomy with additional multiple subpial transactions (one), bilateral ventriculoperitoneal shunt insertion (one), and brain biopsy (one). In all, 19 patients had only postoperative studies.

Hamartoma Properties

Images of 72 patients were included in this analysis. More than one study was reviewed for 49 patients, and the interval between first and last studies reviewed was 4 months to 13 years (average, 41 months). No hypothalamic hamartomas increased in size or changed appreciably in appearance during the interval between studies. The youngest patient studied was 3 months old and had seizure onset from day one; during 4 years of follow-up, the hypothalamic hamartoma decreased in size from 30 × 21 mm to 21 × 14 mm. For the 55 cases in which contrast medium was administered, no enhancement of the lesions was observed. Signal intensity of the hypothalamic hamartoma was increased (relative to cortical and deep gray matter) on T2-weighted images of 67 patients (93%) and was slightly decreased on T1-weighted images of 53 patients (74%); for patients who underwent both conventional spin-echo and fast spoiled gradient-echo imaging, hamartoma hypointensity, when present, was better appreciated on the fast spoiled gradient-echo images and rarely apparent on conventional spin-echo images. Some heterogeneity of solid tissue signal intensity was observed in seven cases (10%). Proton density–weighted or fluid-attenuated inversion recovery imaging was performed in 67 cases, 58 (87%) of which showed relatively high signal intensity compared with gray matter.

The size of hypothalamic hamartomas ranged from 8 to 42 mm in maximum diameter (mean, 19 mm; SD, 8 mm). The position of the lesions in relation to the usual location of the floor of the third ventricle and the hypothalamic regions varied with the size of the lesion (Fig 1). The smallest were entirely or predominantly intraventricular, whereas larger lesions were both intraventricular and interpeduncular. Splaying of one or both cerebral peduncles was present in the largest hamartomas, and eccentric positioning of the basilar artery was observed in two patients. Only two hypothalamic hamartomas were entirely below the floor of the third ventricle, the smaller of which (Fig 2) represents a rare exception to the observation made by Arita et al (22) that the parahypothalamic type of hypothalamic hamartoma is not associated with seizures. The midsagittal view images showed that all 72 hamartomas involved the mammillary region of the hypothalamus and all except six encroached onto the tuber cinereum; 16 large lesions (22%) extended rostrally to abut the optic chiasm, 12 of which also extended to the lamina terminalis in the preoptic region. Two large hypothalamic hamartomas had one or more cystic components with signal intensity similar to that of CSF within the lesion (Fig 3).

Fig 1.

Reformatted T1-weighted (fast spoiled gradient-echo) midsagittal and tilted coronal view MR images of three patients show the range of hypothalamic hamartoma sizes and their locations with respect to regions of the hypothalamus. The smaller lesion (A) is wholly intraventricular and confined to the mammillary region, without encroaching onto the tuber cinereum. The larger lesion (C) extends to the lamina terminalis in the preoptic region, abuts the optic chiasm, and displaces the pituitary stalk. Two hamartomas (A,C) are slightly hypointense relative to cortical and deep gray matter.

Fig 2.

T1-weighted coronal view and T2-weighted midsagittal view MR images show a rare example of an epileptogenic hamartoma located entirely below the floor of the third ventricle. The attachment of this small (6 × 5 × 8 mm diameter) hamartoma is narrowed at the level of the tuber cinereum, and a connection to the right mammillary body can be seen in the sagittal view image, but no distortion of third ventricular outline. This 12-year-old female patient had episodes of crying and laughing from 3 months of age, with increased seizure frequency and associated blank staring, disorientation, and fearfulness from age 9 years; interictal EEG findings were initially normal, but the patient later developed right occipital epileptiform discharges during sleep.

Fig 3.

T1-weighted midsagittal view and T2-weighted axial view MR images show the cystic components of two large hamartomas with interpeduncular, prepontine extension.

A, In the first case, the cyst extends above the roof of the third ventricle and compresses the foramen of Monro on the right, resulting in dilation of the lateral ventricle (arrows).

B, In the second case, the cyst is within and extends below the third ventricle.

Fifteen hamartomas were in contact with the pituitary stalk, six of which displaced the stalk anteriorly, such that the stalk draped over the anterior border of the lesion. The pituitary stalk could not be identified in an additional four patients whose hypothalamic hamartomas had preoptic extension. Comparisons of hamartoma size, location, and involvement of neuroendocrine structures in patients with and without precocious puberty (known for 67 patients) are shown in Table 1. Features that were significantly associated with precocious puberty included larger hamartoma size (P=.004) and contact with the pituitary stalk (P=.01). Absence of tuberal involvement was predictive of normal pubertal development (P=.04).

View this table:

TABLE 1:

Comparison of hypothalamic hamartoma size and other features in patients with and without precocious puberty

Attachment of the hamartoma to the hypothalamus proper was best appreciated on coronal view images. It was bilateral in 27 patients (37%) and predominantly or wholly unilateral in 45 (63%) (Fig 4). Of those identified as having bilateral attachment, 11 (41%) were noted to have greater involvement of one side. Axial and coronal view T2-weighted fast spin-echo images provided the greatest contrast and resolution for identifying intrahypothalamic relationships of the hamartoma. Both postcommissural fornices were identified within the hypothalamus of 66 patients (92%). Where intraventricular extension of the lesion was present (all except two cases), the hypothalamic hamartoma typically displaced the fornix and hypothalamic gray matter anterolaterally on the side of greater hypothalamic attachment. Fornix contact with the hamartoma was unilateral in 44 patients and bilateral in 24; fornix displacement was unilateral in 33 patients and bilateral in 12. According to an accepted definition of the boundary between the tuberal and mammillary regions of the hypothalamus (26), the intrahypothalamic part of the hamartomas therefore occupied mainly the mammillary region, nestled between the postcommissural fornix anteriorly, the mammillary body inferiorly, and the mammillothalamic tract posteriorly (Fig 5). The mammillothalamic tracts were not displaced by the hypothalamic hamartomas despite their intimate relation.

Fig 4.

T2-weighted tilted coronal view image shows an example of a hamartoma with unilateral attachment to the hypothalamus (arrow).

Fig 5.

T2-weighted MR images with magnified views (insets) show the relation of the intra-hypothalamic component of the hamartoma to myelinated fiber tracts and gray matter of the hypothalamus in two patients.

A, Axial section shows anterolateral displacement of the postcommissural fornix on the left when compared with the unaffected right fornix, plus increased T2 signal intensity of the hamartoma relative to the hypothalamus.

B, Parasagittal section obtained at the level of the fornix shows the hamartoma between the postcommissural fornix anteriorly and the mammillothalamic tract posteriorly. Labeled are the postcommissural fornices (black arrows), mammillothalamic tracts (white arrows), and anterior commissure (arrowhead).

Mammillary bodies, or myelinated tissue on the floor of the third ventricle having the appearance of malformed mammillary bodies, could be identified in all except three patients. Displacement or distortion of mammillary tissue was unilateral in 47 patients (68%) and bilateral in 13 (19%). Distorted mammillary tissue could be identified as a thin, medially concave crescent applied to the posterolateral surface of the hamartoma (Fig 6). In 10 patients, mammillary tissue could be identified only unilaterally, and in eight of these patients, there was predominantly or wholly unilateral attachment of the hypothalamic hamartoma to the side on which no identifiable mammillary tissue was present.

Fig 6.

Magnified T2-weighted images of two patients at the level of the mammillary bodies.

A, Axial sections in the first case show inferior displacement and crescent-shaped distortion of the right mammillary body with less marked abnormality on the right.

B, Midsagittal section in the second case shows inferior displacement of the right mammillary body. Axial section is similar in appearance to that shown in A. Labeled are the mammillary bodies (arrows).

Comparison of proton MR spectra between hypothalamic hamartomas (example in Fig7) and normal tissues revealed significant differences in myoinositol (P = .0003) and N-acetylaspartate (P < .0001) concentrations but no differences in choline, creatine, or glutamine plus glutamate concentrations. Post hoc analysis (Table 2) revealed that myoinositol was elevated in hypothalamic hamartomas when compared with either thalamus or frontal lobe, whereas N-acetylaspartate was reduced by comparison.

Fig 7.

Single voxel MR spectrum recorded from a hypothalamic hamartoma showing (from left to right) signal intensity from myoinositol (mI, elevated), total choline (Cho), creatine/phosphocreatine (Cr), and N-acetylaspartate (NAA, reduced) content. The spectrum was recorded from a 4-cm³ region tailored to the hypothalamic hamartomas by using a point-resolved spectroscopy sequence with 3000/30 (TR/TE). The solid line overlaid on the spectrum shows the fitted spectrum produced by LCModel (24), and the upper panel shows the residual of the fit.

View this table:

TABLE 2:

Metabolite concentrations (mean ± SD) in hypothalamic hamartomas of patients compared with the thalamus and frontal lobe of control volunteers

Associated Findings

The whole brain imaging of 69 patients was included in this analysis. Acquired surgical abnormalities were noted in 28 patients (described above) and are not considered further. Seventeen patients (25%) had other abnormalities (Table 3; Figs 8–10). The most frequent finding, noted in 11 patients (16%), was increased T2-weighted signal intensity of the anterior temporal lobe white matter with loss of anterior temporal gray-white matter differentiation (Fig 8); for those with unilateral abnormality (seven patients), this was ipsilateral to the side of predominant hypothalamic hamartoma attachment in every case. Hippocampal sclerosis was not seen and was also not reported as a surgical or histologic finding for the four patients who underwent temporal lobectomy.

Fig 8.

T2-weighted tilted coronal view MR images show an example of bilateral white matter signal intensity abnormality and decreased gray-white matter differentiation in the anterior temporal lobes (image on the left), with normal signal intensity and differentiation in the posterior temporal lobes at the level of the hypothalamic hamartomas (image on the right).

View this table:

TABLE 3:

Associated findings in 69 patients with hypothalamic hamartoma and epilepsy

Malformations of cortical development were observed in only two cases (Fig 10). In the first case, periventricular nodular heterotopia and focal dilation of the left lateral ventricular trigone was associated with mesial occipital and temporal-parietal-occipital convexity cortical thickening and with abnormal gyral configuration, consistent with a transmantle, proliferative-type dysplasia (27). In the second case, the appearance of the medial occipitotemporal and posterior parahippocampal gyri on the left was abnormal, with slight cortical thickening and indistinct gray-white matter differentiation, such that a focal cortical dysplasia was suspected. Intracranial electroencephalography suggested focal seizure onset from the suspect area, but the hypothalamic hamartoma was not explored. Resection of this area of cortex confirmed cortical dysplasia; the microscopic findings included atypical neurons with enlarged nuclei, but the patient’s seizures continued.

Discussion

MR Signal Intensity and Metabolite Profile

Increased T2-weighted signal intensity relative to gray matter, lack of contrast enhancement, and stable lesion size are the most frequently reported MR imaging features of hypothalamic hamartomas (28), and these were confirmed by the present study. Unlike most studies, however, we found slightly decreased T1-weighted signal intensity relative to gray matter in almost three-quarters of our epileptic patients. Previous reports of hypothalamic hamartoma isointensity with gray matter used conventional spin-echo imaging (23, 29–34), in some cases only after IV administration of contrast material (22). Few examples of hypothalamic hamartoma hypointensity shown by conventional spin-echo imaging are found in the literature (35, 36). Our observations may be explained by greater signal intensity contrast among gray matter, white matter, and abnormal tissue obtained with inversion-prepared gradient-echo sequences (such as used in the present study), compared with conventional spin-echo sequences (37). The clinical relevance of T1-weighted and, in particular, T2-weighted contrast between hypothalamic hamartomas and the adjacent hypothalamus is readily apparent in the context of epilepsy surgery, with which the ability to distinguish between hamartoma and hypothalamus is of paramount importance in planning the surgical approach and during the procedure (8, 38). We think that the T2-weighted fast spin-echo sequences of our presurgical imaging protocol provided such contrast (see Figs 5 and 6).

The neurons of hypothalamic hamartomas resemble those of the normal hypothalamus microscopically (39), and the histopathologic findings in this series were in keeping with previous descriptions. Suggestions that epileptogenic hypothalamic hamartomas are distinguished by the presence of dysplastic neurons (12) and balloon cells (6) seem to have resulted from misinterpretation of a previous report (2). However, considerable variation in the relative contribution of neuronal and glial elements can be found, with some authors describing glial cell numbers similar to those seen in normal gray matter (40) and others reporting varying degrees of gliosis, from mild and moderate (33) to dense (41). Different cellular and connective tissue composition of the hypothalamic hamartomas compared with the normal hypothalamus is likely to account for the different signal intensity characteristics we observed in the present series.

Proton MR spectroscopy indicated that the hypothalamic hamartomas in our patients have lower total N-acetylaspartate content and higher myoinositol concentration than either normal thalamic gray matter or frontal lobe tissue composed of both gray and white matter in our normal volunteers. Low N-acetylaspartate concentration is generally interpreted as either neuronal loss or dysfunction (42). A previous qualitative spectroscopic study of five patients with hypothalamic hamartomas found a lower N-acetylaspartate:creatine ratio in the hamartomas as compared with the hypothalamus of normal volunteers (43). The authors suggested that their findings implied neuronal dysfunction within the hypothalamic hamartomas; however, they acknowledged that there is no analogous region in the normal brain that can serve as a control. Our findings could equally be interpreted as reduced neuronal density in the hypothalamic hamartomas compared with other brain tissues. Myoinositol is specific to glial cells, and an increase is most often interpreted as reflecting gliosis (42). The finding of increased hypothalamic hamartoma myoinositol is consistent with an increase in glial tissue compared with normal brain and may also explain the high T2-weighted signal intensity in comparison with normal gray matter that we observed in 93% of our cases. A quantitative study of glial cell numbers in excised hypothalamic hamartoma tissue correlated with MR signal intensity properties (metabolite spectra or T2-relaxometry) could resolve this issue.

Topography and Epileptogenesis

Hypothalamic hamartomas have been classified on the basis of the breadth of attachment to the tuber cinereum—sessile versus pedunculated (33), the presence of more than minimal distortion of the outline of the third ventricle—intrahypothalamic versus parahypothalamic (22), or by using a combination of size, breadth of attachment, distortion of the hypothalamus proper and location of attachment—types Ia, Ib, IIa, and IIb presented by Valdueza et al (21). Some agreement exists among studies that hypothalamic hamartomas associated with epilepsy have sessile attachment to the hypothalamus and displace normal hypothalamic structures, whereas those associated with precocious puberty alone may be pedunculated. Some would classify hypothalamic hamartomas associated with epilepsy according to their preferred microsurgical treatment approach (10).

Our findings largely confirm those of previous small studies in relation to hypothalamic hamartoma topography. The predominantly intraventricular hypothalamic hamartoma is a sessile lesion that corresponds to the intrahypothalamic variety reported by Arita et al (22) and to type IIa presented by Valdueza et al (21); these are the smallest epileptogenic hypothalamic hamartomas. We found that some small hypothalamic hamartomas sat atop the mammillary bodies and did not involve the tuber cinereum (Fig 1A). Patients with such lesions did not develop precocious puberty, which was associated with larger hamartoma size and contact by the hamartoma with the pituitary stalk (Table 1). Because larger hamartoma size in this series was associated with involvement of more anterior hypothalamic regions, it is not possible to say which of the identified factors is key. Small interpeduncular hamartomas are typical for patients with precocious puberty alone, and it has often been stated that among patients with hypothalamic hamartomas and precocious puberty, larger hamartoma size is associated with epilepsy (1, 44, 45). Precocious puberty in hypothalamic hamartomas may be due to autonomous luteinizing hormone-releasing hormone secretion within the hamartoma (46) or induction of hypothalamic pubertal neurendocrine function by secretion of transforming growth factor α (47). It is possible that the location of a hamartoma in relation to the tuber cinereum (predominantly intraventricular versus predominantly interpeduncular) reflects its cellular composition and neuroendocrine potential; large hamartoma size may merely indicate a greater likelihood of combined endocrine and neurologic clinical features.

Arita et al (22) suggested that only the intrahypothalamic type of hypothalamic hamartoma had ample neuronal networks through which epileptogenic neuronal activity could propagate. Notwithstanding the considerable variation in size and differences in degree and direction of extension of epileptogenic hypothalamic hamartomas in this series, the only common feature of all hamartomas in our patients with epilepsy was a connection to one or both mammillary bodies. Particularly well seen in thin section axial view T2-weighted images is the propensity of epileptogenic hypothalamic hamartomas to displace adjacent hypothalamic nuclei and the course of myelinated hypothalamic fiber tracts. The mammillary bodies and their projections, including the anterior thalamic nuclei, are involved in the generation of generalized convulsive seizures elicited by systemic pentylenetetrazol (48). Interruption of both mammillothalamic tracts prevents pentylenetetrazol seizures in experimental animals (19), as does high frequency electrical stimulation of mammillary nuclei (49). In a report of one patient with hypothalamic hamartoma and intractable epilepsy, a stereotactic lesion of one mammillothalamic tract resulted in cessation of generalized seizures whereas partial seizures persisted (9). Although the hypothalamus has many neocortical, limbic, subcortical and brain stem connections (26, 50), the intimate relation of hypothalamic hamartomas to the mammillary bodies and the disposition of the intrahypothalamic component of the hamartoma, encircled by the postcommissural fornix and mammillothalamic tract, suggest a role for these pathways in seizure propagation and perhaps in the progressive epileptogenesis of the syndrome (20).

Associated Brain Malformations

Malformations of cortical development have been described in patients with Pallister-Hall syndrome, in which hypothalamic hamartoma and central polydactyly may be associated with dysplastic nails, pituitary hypoplasia or dysfunction, bifid epiglottis, imperforate anus, and malformations affecting other systems (51). Few examples of nonsyndromal hypothalamic hamartomas with malformations of cortical development are reported, but the additional cerebral malformations in those cases appear similar to those described in cases of Pallister-Hall syndrome (52). Lange-Cosack (53) reported autopsy findings in one patient that included right frontal microgyria and periventricular heterotopia. Schmidt et al (54) described two patients with autopsy findings of right hemisphere microgyria and periventricular heterotopia in one case and heterotopic gray matter with partial agenesis of the corpus callosum in the other. Diebler and Ponsot (1) reported one patient with macrocephaly and evidence of extensive brain malformation shown by CT, including multiple noncommunicating cysts, agenesis of the corpus callosum, and cystic dilation of the cisterna magna. A recent report of one case noted an association with agenesis of the corpus callosum, heterotopic gray matter, and Dandy-Walker complex (55). In the present series, no patients with Pallister-Hall syndrome were included and associated malformations of cortical development were rare, occurring in only two referred patients with refractory epilepsy. We are aware of only three other such patients, one with bilateral schizencephaly (R. Kuzniecky, personal communication, August 2002), one with agenesis of the corpus callosum, culpocephaly, and periventricular heterotopia (J. Zempel, personal communication, February 2003), and one with extensive left mesial frontoparietal pachygyria and heterotopia (P. Shillito, personal communication, June 2003).

The importance of an association between hypothalamic hamartomas and malformations of cortical development is threefold. First, the rarity with which the two apparently combine makes it unlikely that earlier hypotheses concerning the role of additional brain malformations in the genesis of the epileptic and cognitive-behavioral features of the syndrome (1, 23) are correct. Second, the investigation of patients with hypothalamic hamartomas and intractable epilepsy should include MR imaging and interpretation of a sufficient standard to detect associated malformations of cortical development; in the rare event that the two are found together, further investigation may be required to determine their relative contribution to the patient’s neurologic presentation. Third, the pattern of combined cortical and subcortical malformation observed in both syndromal and nonsyndromal hypothalamic hamartomas may indicate a common mechanism for or antecedent to their development. Although mutations in the transcription factor gene GLI3 cause Pallister-Hall syndrome (56, 57), the relationship between GLI3 and nonsyndromal hypothalamic hamartomas is as yet undefined.

Four patients (6%) in the present series had arachnoid cysts. Two other patients had cysts located entirely within the hamartoma, an observation noted previously in cases of large hypothalamic hamartoma (58). Of interest is the spatial relationship between the cysts and the hypothalamic hamartoma. Previous reports have noted that the arachnoid cyst lies adjacent to the hamartoma, which may itself have a cystic component (59–61) or be compressed by the arachnoid cyst (62). The findings for our patients suggest a spectrum of associated cystic abnormalities, including intrahamartomatous cysts (Fig 3), arachnoid cysts that extend within the hamartoma, and arachnoid cysts that are adjacent to or remote from the hypothalamic hamartomas (Fig 9). The cause of congenital intracranial arachnoid cysts is not known, but abnormal splitting of the developing arachnoid membranes has been proposed to relate to focal maldevelopment of the meninges during embryonic folding of the neural tube (63) and in proximity to the normal arachnoid cisterns (64), accounting for both their histopathologic features and characteristic locations. Genetic factors have been implicated in some cases, including a report of familial occurrence (65), monozygous twins with different temporal lobe malformations (schizencephaly in one and arachnoid cyst in the other) (66), and association of bitemporal arachnoid cysts with glutaric aciduria type 1 (67) and neurofibromatosis (68). Although there are no population-based studies of the prevalence of arachnoid cysts, their incidence has been estimated at five per 1000 necropsies (69); this frequency is an order lower than that found in the present series, making a chance association unlikely. Whether the co-occurrence of hypothalamic hamartomas and arachnoid cysts is a result of mechanical influence exerted by the hypothalamic hamartomas during subarachnoid space formation (61) or some other mechanism is speculative.

Fig 9.

Arachnoid cysts associated with hypothalamic hamartomas.

A, T1-weighted coronal view MR image shows a large suprasellar and temporal fossa arachnoid cyst, hypoplasia and compression of the right temporal lobe (bloom artifact due to previous cyst-peritoneal shunt insertion), and cavum septum pellucidum (arrow).

B, T1-weighted coronal view MR image shows a suprasellar arachnoid cyst extending within the hamartoma.

C, T2-weighted axial view MR image shows an anterior temporal arachnoid cyst (arrowhead) remote from the hamartoma (not shown).

Fig 10.

Malformations of cortical development associated with hypothalamic hamartomas in two patients.

A, T2-weighted axial and coronal view MR images in the first case show periventricular nodular heterotopia and focal dilation of the left lateral ventricle, plus overlying calcarine and temporal-parietal-occipital junction cortical thickening and abnormal gyral configuration (white arrows). The hypothalamic hamartoma is seen in the axial view image (arrowhead).

B, Inversion recovery coronal view image obtained at the level of the posterior hippocampus in the second case shows an atypical configuration of the medial occipitotemporal and posterior parahippocampal gyri (black arrow), with slight cortical thickening and indistinct gray-white boundary.

Temporal Lobe Findings

A somewhat surprising finding, considering the refractory and longstanding nature of the epilepsy that occurs in most patients with hypothalamic hamartoma, is the absence of a single case of hippocampal sclerosis. Even in patients who, because of pseudolocalizing clinical and EEG information, had undergone temporal lobe resections in an attempt to control complex partial seizures, the mesial temporal structures were normal. The finding may be explained by the absence of a history of convulsive status epilepticus in these patients, consistent with the view that in temporal lobe epilepsy at least, hippocampal sclerosis results from an initial precipitating injury rather than as a consequence of repeated seizures (70, 71).

Anterior temporal lobe signal intensity abnormalities (increased T2-weighted white matter signal intensity with loss of gray-white matter differentiation) comprised the most frequent associated finding, occurring in 16% of patients. This proportion, however, is considerably less than that reported in patients with temporal lobe epilepsy; approximately two-thirds of those patients have these appearances, usually in association with hippocampal sclerosis (72). Debate surrounds the significance of these anterior temporal abnormalities. Some authors assert that they are a developmental malformation associated with an increase in ectopic white matter neurons (73, 74), whereas others consider that the changes reflect abnormal myelination or demyelination in the temporal lobe (72, 75), an hypothesis supported by the finding of associated reduced temporopolar white matter volume (76) and by a recent study of children with hippocampal sclerosis, in whom anterior temporal signal intensity changes were associated with a very early onset of seizures (77). If the latter hypothesis is correct, anterior temporal lobe changes observed in patients with hypothalamic hamartomas could be a result of seizure propagation from the hypothalamic hamartomas to the temporal lobe. Some evidence for the involvement of the anterior temporal lobe in seizures associated with hypothalamic hamartomas comes from a series of eight patients studied with intracranial EEG, seven of whom had apparent (although falsely localizing) unilateral onset of seizures from the anterior temporal lobe (78). That the unilateral anterior temporal abnormalities in our patients were always ipsilateral to the side of predominant hamartoma attachment to the hypothalamus also suggests some influence of the hypothalamic hamartomas over the temporal changes observed. Further study of seizure origin and spread in patients with hypothalamic hamartoma may clarify this relationship.

Conclusion

Epileptogenic hypothalamic hamartomas are malformations of the mammillary region of the hypothalamus and are invariably attached to one or both mammillary bodies. MR signal intensity characteristics and spectroscopic findings suggest reduced neuronal density and relative gliosis and help to distinguish the hamartoma from the surrounding deep gray matter. The intrahypothalamic component lies in the wall of the third ventricle between the postcommissural fornix anteriorly, the mammillothalamic tract posteriorly, and the mammillary body inferiorly, suggesting a role for these structures in seizure propagation and epileptogenesis. Associated malformations of cortical development are rare, occurring in only 3% of patients in this series, and are unlikely to contribute to the typical clinical syndrome. An association with arachnoid cysts suggests either a common antecedent or causal relationship. Hippocampal sclerosis is not associated with hypothalamic hamartoma, but anterior temporal white matter changes seen in a small proportion may reflect ictal involvement of the temporal lobe during postnatal brain development.

Footnotes

This work was presented at the Australian Association of Neurologists Annual Scientific Meeting, Sydney, 2003.
This work was supported by scholarships from the National Health and Medical Research Council (to J.L.F.), the Murdoch Children’s Research Institute, and the University of Melbourne Faculty of Medicine, Dentistry and Health Sciences.

References

↵
Diebler C, Ponsot G. Hamartomas of the tuber cinereum. Neuroradiology 1983;25:93–101
CrossRef PubMed
↵
Kahane P, Tassi L, Hoffmann D, et al. Dacrystic seizures and hypothalamic hamartoma: apropos of a video-stereo-EEG study [in French]. Epilepsies 1994;6:259–279
Munari C, Kahane P, Francione S, et al. Role of the hypothalamic hamartoma in the genesis of gelastic fits (a video-stereo-EEG study). Electroencephalogr Clin Neurophysiol 1995;95:154–160
CrossRef PubMed
↵
Kahane P, Munari C, Minotti L, et al. The role of the hypothalamic hamartoma in the genesis of gelastic and dacrystic seizures. In: Tuxhorn I, Hothausen H, Boenigk H, eds. Paediatric Epilepsy Syndromes and Their Surgical Treatment. London: John Libbey;1997 :447–461
↵
Kahane P, Di Leo M, Hoffmann D, Munari C. Ictal bradycardia in a patient with a hypothalamic hamartoma: a stereo-EEG study. Epilepsia 1999;40:522–527
CrossRef PubMed
↵
Kuzniecky R, Guthrie B, Mountz J, et al. Intrinsic epileptogenesis of hypothalamic hamartomas in gelastic epilepsy. Ann Neurol 1997;42:60–67
CrossRef PubMed
DiFazio MP, Davis RG. Utility of early single photon emission computed tomography (SPECT) in neonatal gelastic epilepsy associated with hypothalamic hamartoma. J Child Neurol 2000;15:414–417
Abstract/FREE Full Text
↵
Rosenfeld JV, Harvey AS, Wrennall J, Zacharin M, Berkovic SF. Transcallosal resection of hypothalamic hamartomas, with control of seizures, in children with gelastic epilepsy. Neurosurgery 2001;48:108–118
CrossRef PubMed
↵
Palmini A, Chandler C, Andermann F, et al. Resection of the lesion in patients with hypothalamic hamartomas and catastrophic epilepsy. Neurology 2002;58:1338–1347
Abstract/FREE Full Text
↵
Delalande O, Fohlen M. Disconnecting surgical treatment of hypothalamic hamartoma in children and adults with refractory epilepsy and proposal of a new classification. Neurol Med Chir (Tokyo)2003;43:61–68
CrossRef PubMed
↵
Kuzniecky R, Guthrie B, Knowlton R, Faught E, Backensto E. Minimally invasive surgical management of hypothalamic hamartomas in gelastic epilepsy. Epilepsia 2002;43 [Suppl 7]:S348
↵
Fukuda M, Kameyama S, Wachi M, Tanaka R. Stereotaxy for hypothalamic hamartoma with intractable gelastic seizures: technical case report. Neurosurgery 1999;44:1347–1350
CrossRef PubMed
↵
Unger F, Schrottner O, Haselsberger K, Korner E, Ploier R, Pendl G. Gamma knife radiosurgery for hypothalamic hamartomas in patients with medically intractable epilepsy and precocious puberty: report of two cases. J Neurosurg 2000;92:726–731
PubMed
↵
Regis J, Bartolomei F, de Toffol B, et al. Gamma knife surgery for epilepsy related to hypothalamic hamartomas. Neurosurgery 2000;47:1343–1352
CrossRef PubMed
↵
Freeman JL. The anatomy and embryology of the hypothalamus in relation to hypothalamic hamartomas. Epileptic Disord 2003;5:177–186
PubMed
↵
Freeman JL, Zacharin M, Rosenfeld JV, Harvey AS. The endocrinology of hypothalamic hamartoma surgery for intractable epilepsy. Epileptic Disord 2003;5:239–247
PubMed
↵
Miller MJ, Mark LP, Yetkin FZ, et al. Imaging white matter tracts and nuclei of the hypothalamus: an MR- anatomic comparative study. AJNR Am J Neuroradiol 1994;15:117–121
Abstract/FREE Full Text
↵
Saeki N, Sunami K, Kubota M, et al. Heavily T2-weighted MR imaging of white matter tracts in the hypothalamus: normal and pathologic demonstrations. AJNR Am J Neuroradiol 2001;22:1468–1475
Abstract/FREE Full Text
↵
Mirski MA, Ferrendelli JA. Interruption of the mammillothalamic tract prevents seizures in guinea pigs. Science 1984;226:72–74
Abstract/FREE Full Text
↵
Freeman JL, Harvey AS, Rosenfeld JV, Wrennall JA, Bailey CA, Berkovic SF. Generalized epilepsy in hypothalamic hamartoma: evolution and postoperative resolution. Neurology 2003;60:762–767
Abstract/FREE Full Text
↵
Valdueza JM, Cristante L, Dammann O, et al. Hypothalamic hamartomas: with special reference to gelastic epilepsy and surgery. Neurosurgery 1994;34:949–958
PubMed
↵
Arita K, Ikawa F, Kurisu K, et al. The relationship between magnetic resonance imaging findings and clinical manifestations of hypothalamic hamartoma. J Neurosurg 1999;91:212–220
PubMed
↵
Berkovic SF, Andermann F, Melanson D, Ethier RE, Feindel W, Gloor P. Hypothalamic hamartomas and ictal laughter: evolution of a characteristic epileptic syndrome and diagnostic value of magnetic resonance imaging. Ann Neurol 1988;23:429–439
CrossRef PubMed
↵
Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672–679
CrossRef PubMed
↵
Biesecker LG, Abbott M, Allen J, et al. Report from the workshop on Pallister-Hall syndrome and related phenotypes. Am J Med Genet 1996;65:76–81
CrossRef PubMed
↵
Nauta WJ, Haymaker W. Hypothalamic nuclei and fiber connections. In: Haymaker W, Anderson E, Nauta WJ, eds. The Hypothalamus. Springfield: Thomas;1969 :136–209
↵
Barkovich AJ, Kuzniecky RI, Dobyns WB. Radiologic classification of malformations of cortical development. Curr Opin Neurol 2001;14:145–149
CrossRef PubMed
↵
Barkovich AJ. Intracranial, Orbital and Neck Tumors of Childhood: Pediatric Neuroimaging. Philadelphia: Lippincott Williams & Wilkins;2000 :443–580
↵
Peterman SB, Steiner RE, Bydder GM. Magnetic resonance imaging of intracranial tumors in children and adolescents. AJNR Am J Neuroradiol 1984;5:703–709
Abstract/FREE Full Text
Hahn FJ, Leibrock LG, Huseman CA, Makos MM. The MR appearance of hypothalamic hamartoma. Neuroradiology 1988;30:65–68
CrossRef PubMed
Burton EM, Ball WS Jr, Crone K, Dolan LM. Hamartoma of the tuber cinereum: a comparison of MR and CT findings in four cases. AJNR Am J Neuroradiol 1989;10:497–501
Abstract/FREE Full Text
Soto AL, Takahashi M, Yamashita Y, Sakamoto Y, Shinzato J, Yoshizumi K. MRI findings of hypothalamic hamartoma: report of five cases and review of the literature. Comput Med Imaging Graph 1991;15:415–421
CrossRef PubMed
↵
Boyko OB, Curnes JT, Oakes WJ, Burger PC. Hamartomas of the tuber cinereum: CT, MR, and pathologic findings. AJNR Am J Neuroradiol 1991;12:309–314
Abstract/FREE Full Text
↵
Marliani AF, Tampieri D, Melancon D, Ethier R, Berkovic SF, Andermann F. Magnetic resonance imaging of hypothalamic hamartomas causing gelastic epilepsy. Can Assoc Radiol J 1991;42:335–339
PubMed
↵
Karnaze MG, Sartor K, Winthrop JD, Gado MH, Hodges FJ III. Suprasellar lesions: evaluation with MR imaging. Radiology 1986;161:77–82
PubMed
↵
Barral V, Brunelle F, Brauner R, Rappaport R, Lallemand D. MRI of hypothalamic hamartomas in children. Pediatr Radiol 1988;18:449–452
CrossRef PubMed
↵
Klose U, Nagele T, Grodd W, Petersen D. Variation of contrast between different brain tissues with an MR snapshot technique. Radiology 1990;176:578–581
PubMed
↵
Harvey AS, Freeman JL, Rosenfeld JV, Berkovic SF. Transcallosal resection of hypothalamic hamartomas in patients with intractable epilepsy. Epileptic Disord 2003;5:257–265
PubMed
↵
Richter RB. True hamartoma of the hypothalamus associated with pubertas praecox. J Neuropathol Exp Neurol 1951;10:368–383
CrossRef PubMed
↵
Northfield DW, Russell DS. Pubertas praecox due to hypothalamic hamartoma: report of two cases surviving surgical removal of the tumour. J Neurol Neurosurg Psychiatry 1967;30:166–173
FREE Full Text
↵
Georgakoulias N, Vize C, Jenkins A, Singounas E. Hypothalamic hamartomas causing gelastic epilepsy: two cases and a review of the literature. Seizure 1998;7:167–171
PubMed
↵
Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993;13:981–989
Abstract
↵
Tasch E, Cendes F, Li LM, et al. Hypothalamic hamartomas and gelastic epilepsy: a spectroscopic study. Neurology 1998;51:1046–1050
Abstract/FREE Full Text
↵
List CF, Dowman CE, Bagchi BK, Bebin J. Posterior hypothalamic hamartomas and gangliogliomas causing precocious puberty. Neurology 1958;8:164–174
↵
Mahachoklertwattana P, Kaplan SL, Grumbach MM. The luteinizing hormone-releasing hormone-secreting hypothalamic hamartoma is a congenital malformation: natural history. J Clin Endocrinol Metab 1993;77:118–124
CrossRef PubMed
↵
Judge DM, Kulin HE, Page R, Santen R, Trapukdi S. Hypothalamic hamartoma: a source of luteinizing-hormone-releasing factor in precocious puberty. N Engl J Med 1977;296:7–10
PubMed
↵
Jung H, Carmel P, Schwartz MS, et al. Some hypothalamic hamartomas contain transforming growth factor alpha, a puberty-inducing growth factor, but not luteinizing hormone-releasing hormone neurons. J Clin Endocrinol Metab 1999;84:4695–4701
CrossRef PubMed
↵
Coulter DA. Thalamocortical anatomy and physiology. In: Engel J Jr, Pedley TA, eds. Epilepsy: A Comprehensive Textbook. Philadelphia: Lippincott-Raven;1997:341–351
↵
Mirski MA, Fisher RS. Electrical stimulation of the mammillary nuclei increases seizure threshold to pentylenetetrazol in rats. Epilepsia 1994;35:1309–1316
CrossRef PubMed
↵
Saper CB. Hypothalamic connections with the cerebral cortex. Prog Brain Res 2000;126:39–48
CrossRef PubMed
↵
Biesecker LG, Graham JM Jr. Pallister-Hall syndrome. J Med Genet 1996;33:585–589
FREE Full Text
↵
Tsugu H, Fukushima T, Nagashima T, Utsunomiya H, Tomonaga M, Mitsudome A. Hypothalamic hamartoma associated with multiple congenital abnormalities: two patients and a review of reported cases. Pediatr Neurosurg 1998;29:290–296
CrossRef PubMed
↵
Lange-Cosack H. Various groups of hypothalamic precocious puberty. Report: anatomically and clinically uniform group associated with tumors of the tuber cinereum on the floor of a hyperplastic malformation [in German]. Dtsch Z Nervenheilk 1951;166:499–545
↵
Schmidt E, Hallervorden J, Spatz H. The features of hypothalamic hamartomas with and those without precocious puberty [in German]. Dtsch Z Nervenheilk 1958;177:235–262
↵
Gulati S, Gera S, Menon PS, Kabra M, Kalra V. Hypothalamic hamartoma, gelastic epilepsy, precocious puberty: a diffuse cerebral dysgenesis. Brain Dev 2002;24:784–786
CrossRef PubMed
↵
Kang S, Graham JM Jr, Olney AH, Biesecker LG. GLI3 frameshift mutations cause autosomal dominant Pallister-Hall syndrome. Nat Genet 1997;15:266–268
CrossRef PubMed
↵
Freese K, Driess S, Bornholdt D, et al. Gene symbol: GLI3. Disease: Pallister-Hall syndrome. Hum Genet 2003;112:103
CrossRef
↵
Prasad S, Shah J, Patkar D, Gala B, Patankar T. Giant hypothalamic hamartoma with cystic change: report of two cases and review of the literature. Neuroradiology 2000;42:648–650
CrossRef PubMed
↵
Paillas JE, Roger J, Toga M, et al. Hamartoma of the hypothalamus: clinical, radiological and histological study: results of excision [in French]. Rev Neurol (Paris)1969;120:177–194
PubMed
Isaka T, Nakatani S, Yoshimine T, Akai F, Taneda M. Asymptomatic hypothalamic hamartoma associated with an arachnoid cyst: case report. Neurol Med Chir (Tokyo)1996;36:725–728
CrossRef PubMed
↵
Goda M, Tashima A, Isono M, Hori S, Kimba Y. A case of hypothalamic hamartoma associated with arachnoid cyst. Childs Nerv Syst 1999;15:490–492
CrossRef PubMed
↵
Nishio S, Morioka T, Hamada Y, Kuromaru R, Fukui M. Hypothalamic hamartoma associated with an arachnoid cyst. J Clin Neurosci 2001;8:46–48
CrossRef PubMed
↵
Starkman SP, Brown TC, Linell EA. Cerebral arachnoid cysts. J Neuropathol Exp Neurol 1958;17:484–500
↵
Rengachary SS, Watanabe I. Ultrastructure and pathogenesis of intracranial arachnoid cysts. J Neuropathol Exp Neurol 1981;40:61–83
CrossRef PubMed
↵
Pomeranz S, Constantini S, Lubetzki-Korn I, Amir N. Familial intracranial arachnoid cysts. Childs Nerv Syst 1991;7:100–102
PubMed
↵
Briellmann RS, Jackson GD, Torn-Broers Y, Berkovic SF. Twins with different temporal lobe malformations: schizencephaly and arachnoid cyst. Neuropediatrics 1998;29:284–288
CrossRef PubMed
↵
Lutcherath V, Waaler PE, Jellum E, Wester K. Children with bilateral temporal arachnoid cysts may have glutaric aciduria type 1 (GAT1); operation without knowing that may be harmful. Acta Neurochir (Wien) 2000;142:1025–1030
CrossRef PubMed
↵
Martinez-Lage JF, Poza M, Rodriguez CT. Bilateral temporal arachnoid cysts in neurofibromatosis. J Child Neurol 1993;8:383–385
PubMed
↵
Shaw CM, Alvord EC. Congenital arachnoid cysts and their differential diagnosis. In: Vinken PJ, Bruyn GW, eds. Handbook of Clinical Neurology. New York: Elsevier;1977 :75–135
↵
Harvey AS, Grattan-Smith JD, Desmond PM, Chow CW, Berkovic SF. Febrile seizures and hippocampal sclerosis: frequent and related findings in intractable temporal lobe epilepsy of childhood. Pediatr Neurol 1995;12:201–206
CrossRef PubMed
↵
Mathern GW, Babb TL, Armstrong DL. Hippocampal sclerosis. In: Engel J Jr, Pedley TA, eds. Epilepsy: A Comprehensive Textbook. Philadelphia: Lippincott-Raven;1997 :133–155
↵
Mitchell LA, Jackson GD, Kalnins RM, et al. Anterior temporal abnormality in temporal lobe epilepsy: a quantitative MRI and histopathologic study. Neurology 1999;52:327–336
Abstract/FREE Full Text
↵
Martin R, Dowler R, Gilliam F, Faught E, Morawetz R, Kuzniecky R. Cognitive consequences of coexisting temporal lobe developmental malformations and hippocampal sclerosis. Neurology 1999;53:709–715
Abstract/FREE Full Text
↵
Ho SS, Kuzniecky RI, Gilliam F, Faught E, Morawetz R. Temporal lobe developmental malformations and epilepsy: dual pathology and bilateral hippocampal abnormalities. Neurology 1998;50:748–754
Abstract/FREE Full Text
↵
Meiners LC, Witkamp TD, de Kort GA, et al. Relevance of temporal lobe white matter changes in hippocampal sclerosis: magnetic resonance imaging and histology. Invest Radiol 1999;34:38–45
CrossRef PubMed
↵
Coste S, Ryvlin P, Hermier M, et al. Temporopolar changes in temporal lobe epilepsy: a quantitative MRI- based study. Neurology 2002;59:855–861
Abstract/FREE Full Text
↵
Mitchell LA, Harvey AS, Coleman LT, Mandelstam SA, Jackson GD. Anterior temporal changes On MR images of children with hippocampal sclerosis: an effect of seizures on the immature brain? AJNR Am J Neuroradiol 2003;24:1670–1677
↵
Cascino GD, Andermann F, Berkovic SF, et al. Gelastic seizures and hypothalamic hamartomas: evaluation of patients undergoing chronic intracranial EEG monitoring and outcome of surgical treatment. Neurology 1993;43:747–750
Abstract/FREE Full Text

Received May 1, 2003.
Accepted after revision August 26, 2003.

View Abstract

In this issue

Download PDF

Email Article

Citation Tools

Cited By...

More in this TOC Section

Show more PEDIATRICS

[1] ↵
Diebler C, Ponsot G. Hamartomas of the tuber cinereum. Neuroradiology 1983;25:93–101
CrossRef PubMed

[2] ↵
Kahane P, Tassi L, Hoffmann D, et al. Dacrystic seizures and hypothalamic hamartoma: apropos of a video-stereo-EEG study [in French]. Epilepsies 1994;6:259–279

[3] Munari C, Kahane P, Francione S, et al. Role of the hypothalamic hamartoma in the genesis of gelastic fits (a video-stereo-EEG study). Electroencephalogr Clin Neurophysiol 1995;95:154–160
CrossRef PubMed

[4] ↵
Kahane P, Munari C, Minotti L, et al. The role of the hypothalamic hamartoma in the genesis of gelastic and dacrystic seizures. In: Tuxhorn I, Hothausen H, Boenigk H, eds. Paediatric Epilepsy Syndromes and Their Surgical Treatment. London: John Libbey;1997 :447–461

[5] ↵
Kahane P, Di Leo M, Hoffmann D, Munari C. Ictal bradycardia in a patient with a hypothalamic hamartoma: a stereo-EEG study. Epilepsia 1999;40:522–527
CrossRef PubMed

[6] ↵
Kuzniecky R, Guthrie B, Mountz J, et al. Intrinsic epileptogenesis of hypothalamic hamartomas in gelastic epilepsy. Ann Neurol 1997;42:60–67
CrossRef PubMed

[7] DiFazio MP, Davis RG. Utility of early single photon emission computed tomography (SPECT) in neonatal gelastic epilepsy associated with hypothalamic hamartoma. J Child Neurol 2000;15:414–417
Abstract/FREE Full Text

[8] ↵
Rosenfeld JV, Harvey AS, Wrennall J, Zacharin M, Berkovic SF. Transcallosal resection of hypothalamic hamartomas, with control of seizures, in children with gelastic epilepsy. Neurosurgery 2001;48:108–118
CrossRef PubMed

[9] ↵
Palmini A, Chandler C, Andermann F, et al. Resection of the lesion in patients with hypothalamic hamartomas and catastrophic epilepsy. Neurology 2002;58:1338–1347
Abstract/FREE Full Text

[10] ↵
Delalande O, Fohlen M. Disconnecting surgical treatment of hypothalamic hamartoma in children and adults with refractory epilepsy and proposal of a new classification. Neurol Med Chir (Tokyo)2003;43:61–68
CrossRef PubMed

[11] ↵
Kuzniecky R, Guthrie B, Knowlton R, Faught E, Backensto E. Minimally invasive surgical management of hypothalamic hamartomas in gelastic epilepsy. Epilepsia 2002;43 [Suppl 7]:S348

[12] ↵
Fukuda M, Kameyama S, Wachi M, Tanaka R. Stereotaxy for hypothalamic hamartoma with intractable gelastic seizures: technical case report. Neurosurgery 1999;44:1347–1350
CrossRef PubMed

[13] ↵
Unger F, Schrottner O, Haselsberger K, Korner E, Ploier R, Pendl G. Gamma knife radiosurgery for hypothalamic hamartomas in patients with medically intractable epilepsy and precocious puberty: report of two cases. J Neurosurg 2000;92:726–731
PubMed

[14] ↵
Regis J, Bartolomei F, de Toffol B, et al. Gamma knife surgery for epilepsy related to hypothalamic hamartomas. Neurosurgery 2000;47:1343–1352
CrossRef PubMed

[15] ↵
Freeman JL. The anatomy and embryology of the hypothalamus in relation to hypothalamic hamartomas. Epileptic Disord 2003;5:177–186
PubMed

[16] ↵
Freeman JL, Zacharin M, Rosenfeld JV, Harvey AS. The endocrinology of hypothalamic hamartoma surgery for intractable epilepsy. Epileptic Disord 2003;5:239–247
PubMed

[17] ↵
Miller MJ, Mark LP, Yetkin FZ, et al. Imaging white matter tracts and nuclei of the hypothalamus: an MR- anatomic comparative study. AJNR Am J Neuroradiol 1994;15:117–121
Abstract/FREE Full Text

[18] ↵
Saeki N, Sunami K, Kubota M, et al. Heavily T2-weighted MR imaging of white matter tracts in the hypothalamus: normal and pathologic demonstrations. AJNR Am J Neuroradiol 2001;22:1468–1475
Abstract/FREE Full Text

[19] ↵
Mirski MA, Ferrendelli JA. Interruption of the mammillothalamic tract prevents seizures in guinea pigs. Science 1984;226:72–74
Abstract/FREE Full Text

[20] ↵
Freeman JL, Harvey AS, Rosenfeld JV, Wrennall JA, Bailey CA, Berkovic SF. Generalized epilepsy in hypothalamic hamartoma: evolution and postoperative resolution. Neurology 2003;60:762–767
Abstract/FREE Full Text

[21] ↵
Valdueza JM, Cristante L, Dammann O, et al. Hypothalamic hamartomas: with special reference to gelastic epilepsy and surgery. Neurosurgery 1994;34:949–958
PubMed

[22] ↵
Arita K, Ikawa F, Kurisu K, et al. The relationship between magnetic resonance imaging findings and clinical manifestations of hypothalamic hamartoma. J Neurosurg 1999;91:212–220
PubMed

[23] ↵
Berkovic SF, Andermann F, Melanson D, Ethier RE, Feindel W, Gloor P. Hypothalamic hamartomas and ictal laughter: evolution of a characteristic epileptic syndrome and diagnostic value of magnetic resonance imaging. Ann Neurol 1988;23:429–439
CrossRef PubMed

[24] ↵
Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672–679
CrossRef PubMed

[25] ↵
Biesecker LG, Abbott M, Allen J, et al. Report from the workshop on Pallister-Hall syndrome and related phenotypes. Am J Med Genet 1996;65:76–81
CrossRef PubMed

[26] ↵
Nauta WJ, Haymaker W. Hypothalamic nuclei and fiber connections. In: Haymaker W, Anderson E, Nauta WJ, eds. The Hypothalamus. Springfield: Thomas;1969 :136–209

[27] ↵
Barkovich AJ, Kuzniecky RI, Dobyns WB. Radiologic classification of malformations of cortical development. Curr Opin Neurol 2001;14:145–149
CrossRef PubMed

[28] ↵
Barkovich AJ. Intracranial, Orbital and Neck Tumors of Childhood: Pediatric Neuroimaging. Philadelphia: Lippincott Williams & Wilkins;2000 :443–580

[29] ↵
Peterman SB, Steiner RE, Bydder GM. Magnetic resonance imaging of intracranial tumors in children and adolescents. AJNR Am J Neuroradiol 1984;5:703–709
Abstract/FREE Full Text

[30] Hahn FJ, Leibrock LG, Huseman CA, Makos MM. The MR appearance of hypothalamic hamartoma. Neuroradiology 1988;30:65–68
CrossRef PubMed

[31] Burton EM, Ball WS Jr, Crone K, Dolan LM. Hamartoma of the tuber cinereum: a comparison of MR and CT findings in four cases. AJNR Am J Neuroradiol 1989;10:497–501
Abstract/FREE Full Text

[32] Soto AL, Takahashi M, Yamashita Y, Sakamoto Y, Shinzato J, Yoshizumi K. MRI findings of hypothalamic hamartoma: report of five cases and review of the literature. Comput Med Imaging Graph 1991;15:415–421
CrossRef PubMed

[33] ↵
Boyko OB, Curnes JT, Oakes WJ, Burger PC. Hamartomas of the tuber cinereum: CT, MR, and pathologic findings. AJNR Am J Neuroradiol 1991;12:309–314
Abstract/FREE Full Text

[34] ↵
Marliani AF, Tampieri D, Melancon D, Ethier R, Berkovic SF, Andermann F. Magnetic resonance imaging of hypothalamic hamartomas causing gelastic epilepsy. Can Assoc Radiol J 1991;42:335–339
PubMed

[35] ↵
Karnaze MG, Sartor K, Winthrop JD, Gado MH, Hodges FJ III. Suprasellar lesions: evaluation with MR imaging. Radiology 1986;161:77–82
PubMed

[36] ↵
Barral V, Brunelle F, Brauner R, Rappaport R, Lallemand D. MRI of hypothalamic hamartomas in children. Pediatr Radiol 1988;18:449–452
CrossRef PubMed

[37] ↵
Klose U, Nagele T, Grodd W, Petersen D. Variation of contrast between different brain tissues with an MR snapshot technique. Radiology 1990;176:578–581
PubMed

[38] ↵
Harvey AS, Freeman JL, Rosenfeld JV, Berkovic SF. Transcallosal resection of hypothalamic hamartomas in patients with intractable epilepsy. Epileptic Disord 2003;5:257–265
PubMed

[39] ↵
Richter RB. True hamartoma of the hypothalamus associated with pubertas praecox. J Neuropathol Exp Neurol 1951;10:368–383
CrossRef PubMed

[40] ↵
Northfield DW, Russell DS. Pubertas praecox due to hypothalamic hamartoma: report of two cases surviving surgical removal of the tumour. J Neurol Neurosurg Psychiatry 1967;30:166–173
FREE Full Text

[41] ↵
Georgakoulias N, Vize C, Jenkins A, Singounas E. Hypothalamic hamartomas causing gelastic epilepsy: two cases and a review of the literature. Seizure 1998;7:167–171
PubMed

[42] ↵
Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993;13:981–989
Abstract

[43] ↵
Tasch E, Cendes F, Li LM, et al. Hypothalamic hamartomas and gelastic epilepsy: a spectroscopic study. Neurology 1998;51:1046–1050
Abstract/FREE Full Text

[44] ↵
List CF, Dowman CE, Bagchi BK, Bebin J. Posterior hypothalamic hamartomas and gangliogliomas causing precocious puberty. Neurology 1958;8:164–174

[45] ↵
Mahachoklertwattana P, Kaplan SL, Grumbach MM. The luteinizing hormone-releasing hormone-secreting hypothalamic hamartoma is a congenital malformation: natural history. J Clin Endocrinol Metab 1993;77:118–124
CrossRef PubMed

[46] ↵
Judge DM, Kulin HE, Page R, Santen R, Trapukdi S. Hypothalamic hamartoma: a source of luteinizing-hormone-releasing factor in precocious puberty. N Engl J Med 1977;296:7–10
PubMed

[47] ↵
Jung H, Carmel P, Schwartz MS, et al. Some hypothalamic hamartomas contain transforming growth factor alpha, a puberty-inducing growth factor, but not luteinizing hormone-releasing hormone neurons. J Clin Endocrinol Metab 1999;84:4695–4701
CrossRef PubMed

[48] ↵
Coulter DA. Thalamocortical anatomy and physiology. In: Engel J Jr, Pedley TA, eds. Epilepsy: A Comprehensive Textbook. Philadelphia: Lippincott-Raven;1997:341–351

[49] ↵
Mirski MA, Fisher RS. Electrical stimulation of the mammillary nuclei increases seizure threshold to pentylenetetrazol in rats. Epilepsia 1994;35:1309–1316
CrossRef PubMed

[50] ↵
Saper CB. Hypothalamic connections with the cerebral cortex. Prog Brain Res 2000;126:39–48
CrossRef PubMed

[51] ↵
Biesecker LG, Graham JM Jr. Pallister-Hall syndrome. J Med Genet 1996;33:585–589
FREE Full Text

[52] ↵
Tsugu H, Fukushima T, Nagashima T, Utsunomiya H, Tomonaga M, Mitsudome A. Hypothalamic hamartoma associated with multiple congenital abnormalities: two patients and a review of reported cases. Pediatr Neurosurg 1998;29:290–296
CrossRef PubMed

[53] ↵
Lange-Cosack H. Various groups of hypothalamic precocious puberty. Report: anatomically and clinically uniform group associated with tumors of the tuber cinereum on the floor of a hyperplastic malformation [in German]. Dtsch Z Nervenheilk 1951;166:499–545

[54] ↵
Schmidt E, Hallervorden J, Spatz H. The features of hypothalamic hamartomas with and those without precocious puberty [in German]. Dtsch Z Nervenheilk 1958;177:235–262

[55] ↵
Gulati S, Gera S, Menon PS, Kabra M, Kalra V. Hypothalamic hamartoma, gelastic epilepsy, precocious puberty: a diffuse cerebral dysgenesis. Brain Dev 2002;24:784–786
CrossRef PubMed

[56] ↵
Kang S, Graham JM Jr, Olney AH, Biesecker LG. GLI3 frameshift mutations cause autosomal dominant Pallister-Hall syndrome. Nat Genet 1997;15:266–268
CrossRef PubMed

[57] ↵
Freese K, Driess S, Bornholdt D, et al. Gene symbol: GLI3. Disease: Pallister-Hall syndrome. Hum Genet 2003;112:103
CrossRef

[58] ↵
Prasad S, Shah J, Patkar D, Gala B, Patankar T. Giant hypothalamic hamartoma with cystic change: report of two cases and review of the literature. Neuroradiology 2000;42:648–650
CrossRef PubMed

[59] ↵
Paillas JE, Roger J, Toga M, et al. Hamartoma of the hypothalamus: clinical, radiological and histological study: results of excision [in French]. Rev Neurol (Paris)1969;120:177–194
PubMed

[60] Isaka T, Nakatani S, Yoshimine T, Akai F, Taneda M. Asymptomatic hypothalamic hamartoma associated with an arachnoid cyst: case report. Neurol Med Chir (Tokyo)1996;36:725–728
CrossRef PubMed

[61] ↵
Goda M, Tashima A, Isono M, Hori S, Kimba Y. A case of hypothalamic hamartoma associated with arachnoid cyst. Childs Nerv Syst 1999;15:490–492
CrossRef PubMed

[62] ↵
Nishio S, Morioka T, Hamada Y, Kuromaru R, Fukui M. Hypothalamic hamartoma associated with an arachnoid cyst. J Clin Neurosci 2001;8:46–48
CrossRef PubMed

[63] ↵
Starkman SP, Brown TC, Linell EA. Cerebral arachnoid cysts. J Neuropathol Exp Neurol 1958;17:484–500

[64] ↵
Rengachary SS, Watanabe I. Ultrastructure and pathogenesis of intracranial arachnoid cysts. J Neuropathol Exp Neurol 1981;40:61–83
CrossRef PubMed

[65] ↵
Pomeranz S, Constantini S, Lubetzki-Korn I, Amir N. Familial intracranial arachnoid cysts. Childs Nerv Syst 1991;7:100–102
PubMed

[66] ↵
Briellmann RS, Jackson GD, Torn-Broers Y, Berkovic SF. Twins with different temporal lobe malformations: schizencephaly and arachnoid cyst. Neuropediatrics 1998;29:284–288
CrossRef PubMed

[67] ↵
Lutcherath V, Waaler PE, Jellum E, Wester K. Children with bilateral temporal arachnoid cysts may have glutaric aciduria type 1 (GAT1); operation without knowing that may be harmful. Acta Neurochir (Wien) 2000;142:1025–1030
CrossRef PubMed

[68] ↵
Martinez-Lage JF, Poza M, Rodriguez CT. Bilateral temporal arachnoid cysts in neurofibromatosis. J Child Neurol 1993;8:383–385
PubMed

[69] ↵
Shaw CM, Alvord EC. Congenital arachnoid cysts and their differential diagnosis. In: Vinken PJ, Bruyn GW, eds. Handbook of Clinical Neurology. New York: Elsevier;1977 :75–135

[70] ↵
Harvey AS, Grattan-Smith JD, Desmond PM, Chow CW, Berkovic SF. Febrile seizures and hippocampal sclerosis: frequent and related findings in intractable temporal lobe epilepsy of childhood. Pediatr Neurol 1995;12:201–206
CrossRef PubMed

[71] ↵
Mathern GW, Babb TL, Armstrong DL. Hippocampal sclerosis. In: Engel J Jr, Pedley TA, eds. Epilepsy: A Comprehensive Textbook. Philadelphia: Lippincott-Raven;1997 :133–155

[72] ↵
Mitchell LA, Jackson GD, Kalnins RM, et al. Anterior temporal abnormality in temporal lobe epilepsy: a quantitative MRI and histopathologic study. Neurology 1999;52:327–336
Abstract/FREE Full Text

[73] ↵
Martin R, Dowler R, Gilliam F, Faught E, Morawetz R, Kuzniecky R. Cognitive consequences of coexisting temporal lobe developmental malformations and hippocampal sclerosis. Neurology 1999;53:709–715
Abstract/FREE Full Text

[74] ↵
Ho SS, Kuzniecky RI, Gilliam F, Faught E, Morawetz R. Temporal lobe developmental malformations and epilepsy: dual pathology and bilateral hippocampal abnormalities. Neurology 1998;50:748–754
Abstract/FREE Full Text

[75] ↵
Meiners LC, Witkamp TD, de Kort GA, et al. Relevance of temporal lobe white matter changes in hippocampal sclerosis: magnetic resonance imaging and histology. Invest Radiol 1999;34:38–45
CrossRef PubMed

[76] ↵
Coste S, Ryvlin P, Hermier M, et al. Temporopolar changes in temporal lobe epilepsy: a quantitative MRI- based study. Neurology 2002;59:855–861
Abstract/FREE Full Text

[77] ↵
Mitchell LA, Harvey AS, Coleman LT, Mandelstam SA, Jackson GD. Anterior temporal changes On MR images of children with hippocampal sclerosis: an effect of seizures on the immature brain? AJNR Am J Neuroradiol 2003;24:1670–1677

[78] ↵
Cascino GD, Andermann F, Berkovic SF, et al. Gelastic seizures and hypothalamic hamartomas: evaluation of patients undergoing chronic intracranial EEG monitoring and outcome of surgical treatment. Neurology 1993;43:747–750
Abstract/FREE Full Text

Main menu

User menu

Search

American Journal of Neuroradiology

MR Imaging and Spectroscopic Study of Epileptogenic Hypothalamic Hamartomas: Analysis of 72 Cases

Abstract